FollowTheFilings

Managers Activity Compare Newest

Investment

ENLIVEX THERAPEUTICS LTD

Historical 13F holders

CUSIP: M4130Y106
Type: Equity
Class: COM

Period	13F filings
2026 Q1	4
2025 Q4	5
2025 Q3	3
2025 Q2	3
2025 Q1	5
2024 Q4	4
2024 Q3	3

FollowTheFilings · Institutional 13F data room

All managers Activity Compare Newest filings X

Data is sourced from SEC EDGAR as filed. The SEC does not guarantee accuracy or completeness. Holdings exclude shorts and many derivatives; values are as of the report date.